Works matching IS 10538569 AND DT 2023 AND VI 32 AND IP 11
Results: 16
Moxifloxacin monotherapy for treatment of uncomplicated pelvic inflammatory disease: A systematic review and meta‐analysis with trial sequential analysis of randomized controlled trials.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 11, p. 1189, doi. 10.1002/pds.5677
- By:
- Publication type:
- Article
Prescribing of valproate and oral antiepileptics for women of childbearing age and during pregnancy in Germany between 2010 and 2020.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 11, p. 1306, doi. 10.1002/pds.5670
- By:
- Publication type:
- Article
Validation of an algorithm to identify fractures among patients within the Veterans Health Administration.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 11, p. 1290, doi. 10.1002/pds.5662
- By:
- Publication type:
- Article
Accuracy of administrative claims prescription fill data to estimate glucocorticoid use and dose in patients with rheumatoid arthritis.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 11, p. 1271, doi. 10.1002/pds.5660
- By:
- Publication type:
- Article
Validation of diagnosis codes for chorioamnionitis in medical encounter data, 2013–2018.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 11, p. 1280, doi. 10.1002/pds.5659
- By:
- Publication type:
- Article
Identifying inpatient mortality in MarketScan claims data using machine learning.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 11, p. 1299, doi. 10.1002/pds.5658
- By:
- Publication type:
- Article
Barbro Westerholm, 1933–2023.
- Published in:
- 2023
- By:
- Publication type:
- Obituary
Prevalent new user designs: A literature review of current implementation practice.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 11, p. 1252, doi. 10.1002/pds.5656
- By:
- Publication type:
- Article
An algorithm‐based approach to ascertain patients with rare diseases in electronic health records using hypereosinophilic syndrome as an example.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 11, p. 1261, doi. 10.1002/pds.5655
- By:
- Publication type:
- Article
Impact of hemoglobin A1c level on the association between non‐steroidal anti‐inflammatory drug use and cardiovascular events in patients with type 2 diabetes: A population‐based cohort study.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 11, p. 1233, doi. 10.1002/pds.5652
- By:
- Publication type:
- Article
Heterogeneity after harmonisation: A retrospective cohort study of bleeding and stroke risk after the introduction of direct oral anticoagulants in four Western European countries.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 11, p. 1223, doi. 10.1002/pds.5650
- By:
- Publication type:
- Article
Purine antimetabolites associated Pneumocystis jirovecii pneumonia.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 11, p. 1244, doi. 10.1002/pds.5647
- By:
- Publication type:
- Article
Pharmacoepidemiology and Drug Safety's core concepts in pharmacoepidemiology section at 1 year: Where do we go from here?
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 11, p. 1315, doi. 10.1002/pds.5646
- By:
- Publication type:
- Article
Optimizing therapeutic decision‐making for off‐label medicines use: A scoping review and consensus recommendations for improving practice and research<sup>+</sup>.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 11, p. 1200, doi. 10.1002/pds.5640
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 11, p. 1318, doi. 10.1002/pds.5474
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 11, p. 1, doi. 10.1002/pds.5473
- Publication type:
- Article